Literature DB >> 28615307

The role of high-resolution computed tomography in the follow-up of diffuse lung disease: Number 2 in the Series "Radiology" Edited by Nicola Sverzellati and Sujal Desai.

Brett M Elicker1, Kimberly G Kallianos2, Travis S Henry2.   

Abstract

High-resolution computed tomography (HRCT) of the lung is a key component of the multidisciplinary approach to diagnosis in diffuse lung disease (DLD). HRCT also plays an important role in the follow-up of patients with established DLD. In this respect, serial HRCT examinations may provide valuable information that cannot be determined from clinical history and other diagnostic tests, such as pulmonary function tests. Important roles of HRCT in this context include assisting in determining prognosis, monitoring for the efficacy of treatment, detecting progression of disease or complications, and evaluating patients with worsening or acute symptoms. Both clinicians and radiologists should be aware of the expected evolution of HRCT changes in a variety of DLDs. The goals of this paper are to discuss: 1) the expected evolution of HRCT findings over time in common DLDs; 2) the role of serial HRCT examinations in formulating an initial diagnosis; and 3) the role of HRCT in the follow-up of patients with known DLD.
Copyright ©ERS 2017.

Entities:  

Mesh:

Year:  2017        PMID: 28615307     DOI: 10.1183/16000617.0008-2017

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN: 0905-9180


  5 in total

1.  High-Resolution Chest Computed Tomography Imaging of the Lungs: Impact of 1024 Matrix Reconstruction and Photon-Counting Detector Computed Tomography.

Authors:  David J Bartlett; Chi Wan Koo; Brian J Bartholmai; Kishore Rajendran; Jayse M Weaver; Ahmed F Halaweish; Shuai Leng; Cynthia H McCollough; Joel G Fletcher
Journal:  Invest Radiol       Date:  2019-03       Impact factor: 6.016

Review 2.  Challenges in the target volume definition of lung cancer radiotherapy.

Authors:  Susan Mercieca; José S A Belderbos; Marcel van Herk
Journal:  Transl Lung Cancer Res       Date:  2021-04

3.  Interstitial Lung Disease in Systemic Sclerosis: Focus on Early Detection and Intervention.

Authors:  Aryeh Fischer; Nina M Patel; Elizabeth R Volkmann
Journal:  Open Access Rheumatol       Date:  2019-12-09

Review 4.  Monitoring and management of fibrosing interstitial lung diseases: a narrative review for practicing clinicians.

Authors:  Anoop M Nambiar; Christopher M Walker; Jeffrey A Sparks
Journal:  Ther Adv Respir Dis       Date:  2021 Jan-Dec       Impact factor: 5.158

Review 5.  Anti-Inflammatory and/or Anti-Fibrotic Treatment of MPO-ANCA-Positive Interstitial Lung Disease: A Short Review.

Authors:  Hideaki Yamakawa; Yuko Toyoda; Tomohisa Baba; Tomoo Kishaba; Taiki Fukuda; Tamiko Takemura; Kazuyoshi Kuwano
Journal:  J Clin Med       Date:  2022-07-01       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.